SEC Form 5 · accession 0001225208-16-024746
PORTOLA PHARMACEUTICALS INC · PTLA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
A later amendment supersedes this filing — read the amendment. The figures below are kept as originally reported (version chain, not an overwrite).
Reporting owner
Jeffrey W Bird
Director
Period of report
Dec 31, 2015
Accepted (ET)
Jan 26, 2016 · 1:29 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001269021
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F2,F1 | $44.39 | Jun 16, 2015 | A | 10,000 | A | — | Jun 16, 2025 | Common Stock | 10,000 | 10,000 | D |
Explanation of responses
- F1The option shares vest as follow: 1/12 of the shares subject to each option shall vest each month after June 16, 2015, subject to the Reporting Person's Continuous Service (as defined in the Issuer's 2013 Equity Incentive Plan) as of each such date.
- F2The Reporting Person shares pecuniary interest in these shares with other individuals pursuant to a contractual relationship. The Reporting Person disclaims beneficial ownership in these shares except as to the Reporting Person's pecuniary interest in these shares.